Home Your basket
• Recurrences of pleomorphi...
   Price 10.50 €
• A survey of current wound...
   Price 5.50 €
• Laryngeal tuberculosis: a...
   Price 8.50 €
• Adenoid cystic carcinoma ...
   Price 5.50 €
• Mucoepidermoid carcinomas...
   Price 10.50 €
• MIF in Head and Neck canc...
   Price 10.50 €
• Transsexuality: Speech th...
   Price 10.50 €
• Adaptation and validation...
   Price 10.50 €
• The Bell Labs contributio...
   Price 12.50 €
• Toxic nodular goitre asso...
   Price 5.50 €
• Progressive cochleo-vesti...
   Price 5.50 €
• Postural study on healthy...
   Price 10.50 €
• Multidisciplinary daytime...
   Price 12.00 €
• Reconstruction of the ant...
   Price 8.50 €
• Temporal lift...
   Price 10.50 €
• Is ethmoidal adenocarcino...
   Price 10.50 €
• Social consequence of a d...
   Price 10.50 €
• Failure rate and revision...
   Price 10.50 €
• Treatment of acute mastoi...
   Price 8.50 €
• Zenker’s diverticulum in ...
   Price 8.50 €
• Positioning in the oropha...
   Price 8.50 €
• Anosmia following superio...
   Price 5.50 €
• Epitympanic osteoma of th...
   Price 12.50 €
• A simple assessment of qu...
   Price 10.50 €
• Bell's palsy: treatment b...
   Price 5.50 €
• Partial allotransplantati...
   Price 10.50 €
• Temporary loss of visual ...
   Price 8.50 €
• Aesthetic augmentation of...
   Price 10.50 €
• Fungal sinusitis: Report ...
   Price 10.50 €
• Cutaneous horn of the pin...
   Price 5.50 €
• Functional septal surgery...
   Price 10.50 €
• Audit of headache followi...
   Price 5.50 €
• Recurrent ameloblastoma o...
   Price 8.50 €
• Surgery of the semicircul...
   Price 12.50 €

Total Order 310.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2008 o

RHINOLOGY

Immunohistochemistry expression of 3 markers (CEA, UEA-I and Ki-67) in nasal inverted papillomas


Authors : De Gabory L, Deminière C, Stoll D. (Bordeaux)

Ref. : Rev Laryngol Otol Rhinol. 2008;129,3:159-165.

Article published in french
Downloadable PDF document french



Summary : Objectives: Immunohistochemistry evaluation of the expression of degeneration and proliferation markers of the benign form of Schneiderian inverted papillomas in the ORL sphere, in the nondysplastic, dysplastic and degenerated forms. Seeking out an expression profile with a prognostic value. Materials and method: 44 surgical specimens were analyzed in two groups: A= 33 benign and B= 11 degenerated. Group A included: 10 dysplastic lesions, 4 septal lesions and 2 isolated sphenoidal lesions. A simultaneous bipolar localization belonged to the two groups (nasal, benign and otologic malignant). A control group consisted of ten biopsies of healthy mucous membranes harvested during septoplasties. The carcinoembryonic antigen (CEA), the ulex europaeus agglutinin I (UEA-I) and the monoclonal antibody Ki-67 were revealed by immunoreaction with peroxidase and enhanced by streptavidine-biotine. Results: There was a significant difference in the marking of the CEA between the control group and groups A (p< 0.023) and B (p< 0.045). This expression was fulfilled only in the superficial layers in 84.1% of cases. There was no difference in expression between groups A and B, the dysplastic and non-dysplastic inverted papillomas and between the various degrees of dysplasias. There was no significant statistical difference in expression of UEA-I between all the groups and the sub-groups. The expression of Ki-67 was significantly increased in groups A (p< 0.00023) and B (p< 0.05) when compared to the control group. But, no difference existed between groups A and B, the various sub-groups and the benign specific localizations. This expression was present in the basal cells. An expression encompassing all the thickness of the epithelium was generally associated with a degenerated or dysplastic lesion, without being systematic. Conclusion: It was not possible using this specimen and for these three glycoproteins to extricate immunohistochemistry profiles of expression associated to the studied clinical and histological forms. However, the expression of Ki-67 in more than 50% of the cells involving the full epithelium thickness would seem to suggest a particular cellular behavior. Whereas the expression of the protein remains generally confined to the basal and suprabasal layers, a more significant population of Ki-67+ cells disseminated in the epithelium, would signify a tendency of the epithelium to escape the regulation mechanisms. This cellular behavior could constitute a prognostic histological marker but it would require a broader study to be confirmed.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE